For the risk stratification of indeterminate thyroid nodules

Blog
Contact Us
Payment
Physician Portal

Please visit us at ENDOExpo 2024 (Booth 626)

View Observational Study

Go Now

BLOG

Diagnostic Perspectives

View of thyroid case (Hürthle cell)

Oncocytic (formerly Hürthle Cell) Thyroid Nodules: Risk-Stratification with ThyGeNEXT + ThyraMIRv2

View Article

Enhanced Thyroid Nodule Risk Stratification Through microRNA Profiling: A Clinical Case Study

View Article

Insights on Real-world Data of Molecular Testing for Indeterminate Thyroid Nodules

View Article

Confidently Risk-stratify Indeterminate Thyroid Nodules with ThyGeNEXT+ThyraMIRv2

View Article

microRNA Helps Regulate Signaling Pathways in Thyroid Cancer

View Article

ThyraMIRv2 Provides Insight Into Signaling Pathway Genes

View Article

Indeterminate Thyroid Nodules: Mutations and Risk Stratification

View Article

Observational Study Performance Aligns with Clinical Validation Study

View Article

2025 Annual Meeting of the ATA® Poster Provides Insights on Refining Risk in Bethesda III/IV Thyroid Nodules

View Article

2025 Annual Meeting of the ATA® Poster Insights on Thyroid Nodule Testing

View Article